Klin Monbl Augenheilkd 2022; 239(10): 1259-1261
DOI: 10.1055/a-1353-5792
Der interessante Fall

Recalcitrant Herpetic Epithelial Keratitis

Widersprüchliche herpetische epitheliale Keratitis
1   Ocular surface department, Hospital Clínico San Carlos, Madrid, Spain
,
Rosalía Méndez Fernández
1   Ocular surface department, Hospital Clínico San Carlos, Madrid, Spain
,
Federico Sáenz-Francés San Baldomero
2   Glaucoma department, Hospital Clínico San Carlos, Madrid, Spain
,
David Díaz Valle
1   Ocular surface department, Hospital Clínico San Carlos, Madrid, Spain
,
José Manuel Benítez del Castillo
1   Ocular surface department, Hospital Clínico San Carlos, Madrid, Spain
,
Luis Rodríguez Rodríguez
3   Rheumatology department, Hospital Clinico Universitario San Carlos, Madrid, Spain
› Author Affiliations

Introduction

Herpes simplex keratitis (HSK) is a common condition characterized by the appearance of a typical dendritic ulcer, which can lead to progressive corneal scarring and potential visual loss disorders in those complex cases difficult to control and with multiple recurrences. To determine effective therapeutic procedures that avoid further recurrences and minimize disease duration, it is important to ensure a good visual prognosis in these patients.



Publication History

Received: 03 November 2020

Accepted: 11 January 2021

Article published online:
22 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Tsatsos M, MacGregor C, Athanasiadis I. et al. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol 2016; 44: 824-828
  • 2 Brijacak N, Dekaris I, Gagro A. et al. Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis. Coll Antropol 2008; 32: 21-25
  • 3 Rousseau A, Boutolleau D, Titier K. et al. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study. Antiviral Res 2017; 146: 205-212
  • 4 Valerio GS, Lin CC. Ocular manifestations of herpes simplex virus. Curr Opin Ophthalmol 2019; 30: 525-531
  • 5 Heiligenhaus A, Bauer D, Meller D. et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci 2001; 42: 1969-1974
  • 6 Roozbahani M, Hammersmith KM. Management of herpes simplex virus epithelial keratitis. Curr Opin Ophthalmol 2018; 29: 360-364
  • 7 Duan R, de Vries RD, Osterhaus AD. et al. Acyclovir-resistant HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 2008; 198: 659-663
  • 8 Duan R, de Vries RD, van Dun JM. et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 2009; 200: 1402-1414
  • 9 Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998; 339: 300-306
  • 10 Loutsch JM, Sainz B, Marquart ME. et al. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits. Antimicrob Agents Chemother 2001; 45: 2044-2053